Диклориум

Quick links to important sections

Диклориум

Treatment option: Pain, Osteoarthritis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Диклориум

Property Description
Active ingredient Diclofenac (as Sodium, Diethylamine, or Acid)
Form Tablets, Injections, Suppositories, Gels
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief from pain, inflammation, and fever
Origin Synthetic (Phenylacetic Acid Derivative)

What Type of Medicine is Диклориум (Diclofenac)?

Диклориум is a medicinal preparation whose core active component is Diclofenac, classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This is a synthetic, single-ingredient medicine derived chemically from phenylacetic acid. Diclofenac is specifically distinguished within the NSAID group by its structural identity as a benzeneacetic acid derivative, which is distinct from propionic acid derivatives like ibuprofen. The compound exists in various forms, such as Diclofenac Sodium for systemic use or Diclofenac Diethylamine used in topical preparations, offering flexibility for different therapeutic approaches.


What is the General Purpose of Diclofenac's Action?

The general purpose of Диклориум is to provide symptomatic relief by selectively interrupting the key pathways associated with discomfort. Its fundamental mechanism involves inhibiting the synthesis of prostaglandins, which are molecules that mediate pain, inflammation, and fever in the body. By reducing the production of these localized mediators, the medicine works by addressing the substances that contribute to symptoms of swelling and pain. Диклориум provides analgesic (pain relief), anti-inflammatory action (swelling and redness reduction), and an antipyretic effect (fever reduction).


Available Preparations and Identity Variations

The substance Diclofenac is formulated across multiple dosage forms to accommodate various routes of administration, including Oral, Rectal, Parenteral (by injection), and Topical. The availability of diverse pharmaceutical preparations—such as specialized enteric-coated oral tablets to reduce gastric irritation, solutions for injection, and topical gels—is a distinguishing feature of the Diclofenac identity. This range allows the core active ingredient to be applied systemically or locally, facilitating control over acute inflammatory episodes or localized pain.

What side effects are possible with Диклориум?

Possible Side Effects and Safety Information

Диклориум (Diclofenac) is associated with an increased risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may increase with the duration of use and the dose administered. Patients with pre-existing cardiovascular disease or significant risk factors are at greater risk.


Key Adverse Reactions and Safety Warnings

Adverse events fall primarily within Gastrointestinal, Cardiovascular, Renal, and Hepatobiliary system-organ classes.

Serious Adverse Reactions

  • Gastrointestinal: The drug increases the risk of serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines. These events can occur without warning symptoms and may be fatal.
  • Cardiovascular: Beyond the thrombotic risk, NSAIDs can lead to the onset of new hypertension or worsening of pre-existing hypertension, and may cause fluid retention and edema, potentially leading to or worsening heart failure.
  • Hepatic and Renal: Hepatotoxicity (liver damage) and renal toxicity (kidney damage), including acute renal failure and papillary necrosis, have been reported.

Common Adverse Reactions

Commonly reported side effects include gastrointestinal symptoms such as nausea, indigestion, diarrhea, constipation, and abdominal pain. Dizziness, headache, and tinnitus (ringing in the ears) are also frequently noted.


Safety Restrictions and Population Considerations

The drug is contraindicated in patients with established ischemic heart disease, peripheral arterial disease, cerebrovascular disease, or congestive heart failure (NYHA Class II–IV). The lowest effective dose for the shortest possible duration should be used to minimize the potential for adverse cardiovascular and GI events. Elderly patients are at a higher risk for serious adverse events, and specific precautions apply regarding use during the third trimester of pregnancy due to risk to the fetus.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Diclofenac documents a range of clinical manifestations primarily affecting the gastrointestinal and central nervous systems. Documented presentations include nausea, vomiting (which may contain blood or resemble coffee grounds), abdominal pain, dizziness, drowsiness, headache, and ringing in the ears (tinnitus). Other signs include rash, wheezing, and oliguria (little to no urine output).

Severe overdose may escalate to life-threatening outcomes such as gastrointestinal bleeding, ulceration, and potentially fatal perforation. Other serious complications include convulsions, coma, acute renal failure, and liver failure. A large overdose can be very harmful to both children and adults.

Mandatory Emergency Action

Immediate medical attention is required for any suspected overdose. Contact emergency services immediately if the person experiences severe clinical symptoms such as seizures, loss of consciousness, or severe breathing difficulties. Official guidelines also mandate seeking emergency help for signs of a severe anaphylactic reaction.

Management is largely symptomatic and supportive because no specific antidotes are known for acute NSAID toxicity. Supportive measures may include the administration of activated charcoal and gastric lavage, if indicated. Close monitoring of vital signs and renal function is essential, particularly for elderly patients, who are at greater risk for serious gastrointestinal events following exposure.

Therapeutic Uses of Диклориум

The therapeutic application of Диклориум (Diclofenac) is commonly used in situations involving certain distressing symptoms related to inflammatory or irritative states, where the medication may be part of symptomatic management across several therapeutic domains.

It is commonly used to help with symptoms of conditions where functional stability becomes affected, including Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. It assists in addressing symptoms associated with acute or disruptive episodes, such as the discomfort of gout, acute migraine, or primary dysmenorrhea, and is relevant for easing symptoms related to inflammatory or irritative states following strains or procedures.

It provides support that helps ease the overall symptom burden, contributes to improved comfort during periods of heightened symptoms, and may assist with maintaining functional stability.

Quick Fact: Relief for Joint Pain and Inflammation

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Диклориум (Diclofenac) — Official Regulatory Information


Eligibility scope

  • Populations for whom use is allowed (as stated in label): Adults (18 years and older) are the primary eligible population for systemic use, subject to screening for contraindications.

  • Populations for whom use is contraindicated: Patients with known hypersensitivity to Diclofenac or other NSAIDs; active gastrointestinal (GI) bleeding, ulceration, or perforation; severe renal impairment or severe hepatic impairment; severe congestive heart failure (NYHA Class III–IV), established ischemic heart disease; and pregnant individuals at or after 20 weeks of gestation.

  • Age-related eligibility rules: Older Adults require use with caution at the lowest effective dose. Pediatric use (children/adolescents) for many systemic forms is often not established or not recommended, with eligibility dependent on formulation and specific age thresholds.

  • Pregnancy and lactation eligibility status (if explicitly documented): Use is contraindicated from 20 weeks gestation onward. Use in the first and second trimesters, as well as during lactation, is generally not recommended.

  • Eligibility-related restrictions: Caution is mandatory for patients with uncontrolled hypertension, cardiovascular risk factors, or a prior history of GI disease.


Connection to the overall eligibility profile

Official regulatory documents define Diclofenac's eligibility profile by establishing absolute prohibitions based on severe systemic risks, including active GI pathology, serious cardiovascular disease, severe organ failure, and late-stage pregnancy. Other populations, such as the elderly and those with mild-to-moderate organ impairment, are permitted use only under explicit cautionary restrictions.

What should I know about interactions with other medicines?

Official Interaction Profile for Диклориум (Diclofenac)

The official interaction profile for Diclofenac is documented in government regulatory sources, focusing on pharmacokinetic and pharmacodynamic constraints with other medicines and products. All statements are based on labeled prescribing information.

Category Official Regulatory Documentation Statement
Medicinal product categories NSAIDs, Drugs that interfere with hemostasis, ACE Inhibitors, ARBs, Diuretics, CYP2C9 Inhibitors.
Specific interacting medicines Lithium, Digoxin, Methotrexate, Voriconazole, Warfarin, Aspirin.
Mechanistic basis Metabolism is primarily mediated by CYP2C9. Co-administration with the CYP inhibitor Voriconazole significantly increases Diclofenac exposure ( AUC by 78%).
Interaction-related restrictions Use is contraindicated in the setting of Coronary Artery Bypass Graft ( CABG) Surgery.

Official Interaction Statements:

  • Diclofenac can increase the serum concentration of Lithium, Digoxin, and Methotrexate, due to reduced renal clearance or competitive binding.
  • Concurrent use with other NSAIDs increases the documented risk of serious Gastrointestinal adverse events (e.g., bleeding, ulceration).
  • Co-administration with ACE Inhibitors or ARBs may diminish the antihypertensive effect and result in deterioration of renal function. This risk is explicitly noted as higher in elderly, volume-depleted, or renal-impaired patients.
  • Food or Antacids decrease the rate but not the extent of Diclofenac absorption.

Connection to the overall interaction profile (2–4 sentences): The regulatory profile defines the interaction structure through mandated contraindications (CABG) and by establishing additive risk for organ systems (GI and renal) when used alongside other specific drug classes. It formally details interactions that significantly increase the concentration of co-administered narrow-therapeutic-index drugs, thus setting the documented limits for co-administration.

Mechanism of Action

Modulating Key Inflammatory Mediators via COX Inhibition

The core mechanism involves the inhibition of Cyclooxygenase (COX) enzymes (both COX-1 and COX-2). This action restricts the synthesis of prostaglandins, which are key chemical mediators of pro-inflammatory and pro-nociceptive responses. By suppressing this specific biochemical pathway, the mechanism restricts the physiological signaling pathways associated with local edema and increased nociceptor sensitivity.


Dual Action on Nociceptive Signaling and Thermoregulation

The molecule's mechanism extends beyond local pathways to include two distinct, system-level actions. Firstly, it reduces the creation of prostaglandins in the hypothalamus, which results in the modulation of the thermoregulatory setpoint. Secondly, non-prostaglandin mechanisms, such as ion channel modulation (KATP channels), results in the stabilization and reduction of the excitability of peripheral pain-sensing neurons, thereby reducing the efficiency of signal transmission.


️ Mechanistic Scope and Biological Constraints

The resulting physiological change is confined to mediator modulation. The mechanism does not intervene in the underlying etiology of the pathology. Consequently, the mechanism’s scope of action is biologically constrained to processes driven by prostaglandin release; the functional activity of the mechanism is reduced in situations where nociceptive signals arise predominantly from non-prostaglandin-dependent pathways.

Dosage and Administration Information

Official Administration Guidelines for Diclofenac

The administration of Diclofenac is governed by principles that standardize its route, dose, and frequency. A standard principle for systemic use is the application of the lowest effective dose for the shortest duration possible.


Administration Scope

Instruction Details
Route of Administration The medicine is used via the Oral (tablets, capsules, powder), Rectal (suppositories), Parenteral (IV/IM), and Topical (gel/solution) routes.
Dosing Schedule Standard total daily doses for chronic conditions typically range from 100 mg to 150 mg in divided doses, with a general maximum daily limit of 150 mg for most systemic forms. Intravenous administration is scheduled as 37.5 mg every 6 hours, not to exceed 150 mg per day.
Timing in relation to meals Oral tablets are typically taken with or after food; however, specific formulations like the oral powder solution are intended to be consumed on an empty stomach after mixing with water.
Preparation Requirements Delayed-release and extended-release tablets are designed to be swallowed whole and are not crushed, cut, or chewed, as this alters the intended release profile.
Population-Specific Rules Protocols for older adults and patients with mild organ impairment generally involve initiating treatment at the lowest end of the established dosing range.

Procedural Structure

The use protocol involves selecting a specific formulation based on the required route, then administering the minimum necessary dose according to a fixed schedule (e.g., BID or TID). This structured approach, emphasizing dose minimization and limited duration, characterizes the therapeutic application of the substance.

Recent Clinical Evidence

Research evidence / Overview of studies for Диклориум (Diclofenac)

Evidence for Use in Chronic Joint and Inflammatory Conditions

Research involving Randomized Controlled Trials (RCTs) and systematic reviews has evaluated Diclofenac in research exploring how symptoms change over time related to Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Ankylosing Spondylitis (AS). These studies primarily measure patient-reported outcomes describing perceived discomfort, focusing on metrics such as changes in pain intensity, joint swelling, and functional activity levels. Findings describe patterns observed in the studies where these metrics were tracked in adult populations with established chronic conditions. For RA, research explored short-term symptom changes and was not designed to examine whether the medicine's use was associated with changes in the long-term course of the underlying disease.

Evidence for Use in Acute Pain and Symptom Management

The research base also includes short-term, acute RCTs examining Diclofenac for sudden, short-lived symptoms, including acute post-procedural pain, Primary Dysmenorrhea, and Acute Migraine attacks. Trials monitor the time it took for patients to report a specific change in their pain metric and track the need for rescue analgesia. For Acute Migraine, studies focused on outcomes reflecting how many patients achieved a pain-free status two hours after use, but the research remains strictly focused on the acute episode, not on prevention.

Long-Term Research and Research Gaps

Controlled studies have frequently compared Diclofenac against an inactive placebo to monitor differences in how symptoms evolved in the observed populations, as well as against alternative pharmaceutical comparators. While short-term study periods are well-documented, long-term effects are not fully established for all aspects of chronic use. Data for certain patient groups, such as those with specific comorbid conditions or very small sample sizes, remain insufficient. Research is cited as mixed regarding whether the medicine’s long-term use was associated with changes to the structural progression in conditions like Ankylosing Spondylitis. Evidence quality varies across studies, and some older trials may have had methodological limitations.

Key Studies & References

  1. Diclofenac: MedlinePlus Drug Information – General Uses

Frequently Asked Questions (FAQ)

Common questions about Диклориум (FAQ)


Q: Can Диклориум be taken with common over-the-counter pain relievers?

Official regulatory documents advise against taking Diclofenac with other nonsteroidal anti-inflammatory drugs (NSAIDs), including Aspirin. Combining these types of medicines increases the risk of serious side effects, such as gastrointestinal bleeding. Official labeling primarily focuses on interactions with other NSAIDs and blood thinners.


Q: Is Диклориум safe for people with a sensitive stomach?

Diclofenac carries a documented warning of serious gastrointestinal (GI) adverse events, which can include bleeding and ulceration, sometimes without warning symptoms. Patients who have a prior history of GI problems are known to have a higher risk. Official information states that caution is necessary for individuals with a prior history of gastrointestinal problems.


Q: Are there any foods I should avoid when using Диклориум?

The official product information states that taking Diclofenac with food decreases the rate but not the extent of absorption. This effect means the rate of absorption may be delayed when the medication is consumed with food. Specific foods that must be avoided are not typically detailed beyond the general effect of food delaying absorption.


Q: Does Диклориум affect blood pressure?

Yes, regulatory documents indicate that NSAIDs like Diclofenac can potentially lead to a new onset of high blood pressure (hypertension) or cause existing high blood pressure to worsen. It is advised that blood pressure should be monitored during treatment.


Q: What's the difference between Диклориум and Ibuprofen?

Both are classified as Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and share a similar function. Diclofenac is chemically categorized as a benzeneacetic acid derivative, distinct from Ibuprofen, which is a propionic acid derivative. The official labeling notes that all NSAIDs are associated with the same core class warnings regarding cardiovascular and gastrointestinal risks.


Q: Does Диклориум interact with blood thinners?

Yes, Diclofenac is known to interact with medicines that interfere with blood clotting. Specifically, it can interact with anticoagulants like Warfarin and antiplatelet agents such as Aspirin. Official documents indicate that this combination may increase the risk of serious bleeding events.


Q: What is the typical onset time for pain relief with Диклориум?

According to the official clinical pharmacology information, the time to reach maximum plasma concentration (Tmax) for some oral forms is around 2.3 hours. While this reflects when the medication peaks in the bloodstream, the actual onset of pain relief may be noted sooner, especially with immediate-release versions.


Q: Why do some people report stomach upset when they take Диклориум?

Stomach upset is a very common adverse reaction listed in the official documents. Symptoms such as nausea, indigestion, abdominal pain, diarrhea, and constipation are frequently reported side effects associated with the use of Diclofenac.


Q: What are the signs of an allergic reaction to Диклориум?

Official warnings note that Diclofenac can cause serious allergic reactions, known as anaphylaxis. Signs of this can include hives, difficulty breathing, and swelling of the face or throat. If any signs of a severe reaction occur, immediate medical attention is necessary.


Q: Is it necessary to take Диклориум with food?

Regulatory information indicates that taking the medicine with food can delay the rate at which the medication is absorbed. While this can help mitigate stomach irritation, it is not always strictly necessary and depends on the specific formulation being used.


Q: How does the action of Диклориум compare to simple Tylenol (Paracetamol)?

Diclofenac is an NSAID, meaning its primary function is to inhibit the production of prostaglandins, which are key molecules in pain and inflammation. While both medicines relieve pain and fever, Paracetamol (Acetaminophen) has a different primary mechanism and is not classified as an NSAID.


Q: Are there any known interactions between Диклориум and herbal remedies?

While the core drug label does not list every specific herbal remedy, it does generally caution against taking Diclofenac with any products that may interfere with blood clotting. Combining the medicine with such products could increase the potential risk of bleeding.


Q: Is there a generic version of Диклориум?

Yes, the active component of this medication is Diclofenac. Diclofenac is widely available as a generic drug under its scientific name, in addition to being sold under various brand names.


Q: Why does Диклориум sometimes cause drowsiness?

The official documentation lists drowsiness as a reported adverse experience associated with Diclofenac. Other central nervous system effects, such as dizziness, headache, anxiety, and insomnia, have also been reported.


Q: What should I do if the side effects from Диклориум bother me?

Official patient materials suggest that bothersome or concerning symptoms should be discussed with a healthcare professional. This is especially important if signs of a serious adverse event are noticed.


Q: Does Диклориум interact with anxiety or depression medications?

Official information indicates that Diclofenac can interact with Lithium, which is used to treat bipolar disorder, potentially increasing its concentration. Additionally, some regulatory warnings caution against co-administration with SSRIs (a class of depression and anxiety medication) due to a possible increased risk of bleeding.


Q: Why are there different forms of Диклориум (e.g., tablet, gel)?

Diclofenac is offered in multiple dosage forms, including oral tablets, injections, and topical gels, to allow for different routes of administration. This flexibility allows healthcare providers to choose the most appropriate form for the patient's condition, such as local use for joint pain or systemic use for acute episodes.


Q: Can children or teenagers use Диклориум for pain relief?

The safety and effectiveness of Diclofenac in pediatric patients (children and adolescents) have not been established for many systemic forms. However, some specific formulations are approved for use in patients aged 12 years and older for the treatment of certain types of acute pain.


Q: What is the role of Диклориум in managing post-operative pain?

Diclofenac is indicated for the relief of acute pain, which can include pain experienced after a medical procedure. However, regulatory documents explicitly state that the medicine is contraindicated (must not be used) to treat peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.


Q: Does Диклориум have any effect on sleep?

The official adverse reaction lists include insomnia, which is difficulty sleeping, as an experience that has been reported by patients using Diclofenac.


Q: What evidence supports the use of Диклориум in treating gout?

While the core FDA label for oral tablets does not explicitly list gout as an approved indication, it is indicated for other inflammatory conditions. Clinical information regarding its use is specific to the approved indications listed.


Q: Can Диклориум be used for dental pain after an extraction?

Official indications show that some specific forms of Diclofenac are approved for the management of mild to moderate acute pain. This commonly includes pain following surgical procedures like a dental extraction.


Q: What are some key differences between Диклориум and other NSAIDs?

While all NSAIDs share the same fundamental mechanism of action and the same serious warnings for cardiovascular and gastrointestinal events, Diclofenac is chemically distinct from propionic acid derivatives like Ibuprofen or Naproxen. Regulatory information notes these class-wide warnings.

How should Диклориум be stored and disposed of?

Official Storage and Disposal Guidelines

Storage and disposal requirements for Diclofenac (Диклориум) are defined by government regulatory agencies to maintain product integrity and ensure safety.

Storage Requirement Rule Defined by Regulatory Labeling
Temperature Store at room temperature (20 C to 25 C / 68 F to 77 F) and keep from freezing
Protection Keep in the closed, original container and protect from light and moisture.
Child Safety Keep out of the reach of children.

Disposal must follow the instructions from your healthcare professional and align with local requirements. Unused or expired product should not be allowed to enter the sewage system or aquatic environment, as regulatory documents indicate Diclofenac poses a risk to aquatic life.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Диклориум found in:

A-Z Index: